Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin plus quinine versus Coartem in Kenyan children with uncomplicated falciparum malaria
PACTR201209000419241Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- Nov 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of clindamycin, quinine and lumefantrine in Malaria (2 arms), sponsored by Kenya Medical Research Institute. Primary endpoint: Cure rate. Started Nov 2012; status: completed.
02
Drugs
clindamycinquininelumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201209000419241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201209000419241.